Published in Am J Ophthalmol on April 24, 2007
Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up. Graefes Arch Clin Exp Ophthalmol (2011) 2.17
Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol (2013) 2.07
Inflammatory choroidal neovascular membrane in posterior uveitis-pathogenesis and treatment. Indian J Ophthalmol (2009) 1.24
Intravitreal bevacizumab for refractory choroidal neovascularization (CNV) secondary to uveitis. Graefes Arch Clin Exp Ophthalmol (2008) 1.04
Management of uveitis-related choroidal neovascularization: from the pathogenesis to the therapy. J Ophthalmol (2014) 0.95
Optical coherence tomography imaging in uveitis. Int Ophthalmol (2013) 0.94
[White dot syndrome]. Ophthalmologe (2008) 0.93
Verteporfin PDT for non-standard indications--a review of current literature. Graefes Arch Clin Exp Ophthalmol (2010) 0.90
Successful treatment of choroidal neovascular membrane in retinitis pigmentosa with intravitreal bevacizumab. Int Ophthalmol (2010) 0.90
[Unilateral metamorphopsia of a young woman]. Ophthalmologe (2010) 0.88
[Central serous chorioretinopathy (CSC)]. Ophthalmologe (2010) 0.87
Bevacizumab in inflammatory eye disease. Am J Ophthalmol (2009) 0.86
Intravitreal bevacizumab: an analysis of the evidence. Clin Ophthalmol (2007) 0.84
Advances in the treatment of central serous chorioretinopathy. Saudi J Ophthalmol (2015) 0.82
Punctate inner choroidopathy: a clinical case report. Case Rep Ophthalmol (2013) 0.82
Intravitreal bevacizumab for choroidal neovascularization secondary to non-age-related macular degeneration. J Ophthalmic Vis Res (2010) 0.82
Photodynamic therapy for choroidal neovascularization in young adult patients. Int Ophthalmol (2010) 0.81
[Intravitreal bevacizumab for chronic central serous chorioretinopathy]. Ophthalmologe (2008) 0.81
Using spectral-domain optical coherence tomography to follow outer retinal structure changes in a patient with recurrent punctate inner choroidopathy. J Ophthalmol (2011) 0.80
Successful treatment of melanocytoma associated choroidal neovascular membrane with intravitreal bevacizumab. Saudi J Ophthalmol (2013) 0.80
Punctate inner choroidopathy: a systematic review. Med Hypothesis Discov Innov Ophthalmol (2014) 0.80
Peripapillary Neovascular Membrane in a Young Pregnant Woman and Prompt Response to Ranibizumab Injections following Uneventful Delivery. Case Rep Ophthalmol (2011) 0.79
Novel Intraocular Therapy in Non-infectious Uveitis of the Posterior Segment of the Eye. Med Hypothesis Discov Innov Ophthalmol (2013) 0.77
Intravitreal Anti-VEGF Injections in Pregnancy: Case Series and Review of Literature. J Ocul Pharmacol Ther (2015) 0.76
Optical coherence tomography characteristics of responses to intravitreal bevacizumab in idiopathic choroidal neovascularization. Int J Ophthalmol (2016) 0.76
[Experiences with chronic central serous chorioretinopathy treated with half-dose photodynamic therapy and verteporfin]. Ophthalmologe (2011) 0.76
Efficacy and safety of conbercept as a primary treatment for choroidal neovascularization secondary to punctate inner choroidopathy. BMC Ophthalmol (2017) 0.76
Evaluation of Idiopathic Choroidal Neovascularization with Indocyanine Green Angiography in Patients Undergoing Bevacizumab Therapy. J Ophthalmol (2015) 0.75
Ranibizumab in choroidal neovascularisation associated with ocular sarcoidosis. BMJ Case Rep (2013) 0.75
Five-year visual results of intravitreal bevacizumab in refractory inflammatory ocular neovascularization. Clin Ophthalmol (2012) 0.75
A 39-year-old woman with unilateral metamorphosias. Digit J Ophthalmol (2011) 0.75
Combined treatment in punctate inner choroidopathy. Ther Clin Risk Manag (2016) 0.75
The use of intravitreal ranibizumab for choroidal neovascularization associated with vogt-koyanagi-harada syndrome. Case Rep Med (2011) 0.75
Intravitreal bevacizumab for subfoveal choroidal neovascularization complicating active central serous chorioretinopathy. Indian J Ophthalmol (2011) 0.75
Optical Coherence Tomography Angiography Of Pathological Myopia Sourced and Idiopathic Choroidal Neovascularization With Follow-Up. Medicine (Baltimore) (2016) 0.75
Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis). Trans Am Ophthalmol Soc (2015) 0.75
Meta-analysis of best corrected visual acuity after treatment for myopic choroidal neovascularisation. Int J Ophthalmol (2014) 0.75
Surgical management and ultrastructural study of choroidal neovascularization in punctate inner choroidopathy after bevacizumab. J Ophthalmic Inflamm Infect (2011) 0.75
HTRA1 promoter polymorphism in wet age-related macular degeneration. Science (2006) 7.12
Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology (2011) 4.96
Randomized controlled trial of patching vs acupuncture for anisometropic amblyopia in children aged 7 to 12 years. Arch Ophthalmol (2010) 3.92
Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract. Ophthalmology (2012) 3.44
Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma. Nat Genet (2010) 2.75
Asymmetrical ocular involvement and persistent fetal vasculature in an adult with osteoporosis-pseudoglioma syndrome. Arch Ophthalmol (2006) 2.66
Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series. Ophthalmology (2004) 2.49
Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology (2009) 2.41
Comparison of macular thickness measurements between time domain and spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci (2008) 2.37
Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy. Am J Ophthalmol (2005) 2.21
Orthokeratology lens-related corneal ulcers in children: a case series. Ophthalmology (2004) 2.20
Eyelid tumours and pseudotumours in Hong Kong: a ten-year experience. Hong Kong Med J (2013) 2.14
Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study. Retina (2008) 2.06
Prevalence, incidence, and progression of myopia of school children in Hong Kong. Invest Ophthalmol Vis Sci (2004) 2.04
Intravitreal Injection-Technique and Safety. Asia Pac J Ophthalmol (Phila) (2015) 2.03
Agreement among 3 methods to measure corneal thickness: ultrasound pachymetry, Orbscan II, and Visante anterior segment optical coherence tomography. Ophthalmology (2007) 1.94
Transient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy. Am J Ophthalmol (2004) 1.91
Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial. Ophthalmology (2008) 1.88
Comparison between central corneal thickness measurements by ultrasound pachymetry and optical coherence tomography. Clin Experiment Ophthalmol (2006) 1.71
Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). J Glaucoma (2010) 1.71
Epiretinal membrane formation with internal limiting membrane wrinkling after Nd:YAG laser membranotomy in valsalva retinopathy. Am J Ophthalmol (2003) 1.70
Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. Am J Ophthalmol (2006) 1.69
Indocyanine green-assisted internal limiting membrane removal in epiretinal membrane surgery: a clinical and histologic study. Am J Ophthalmol (2004) 1.69
Retinal redetachment after silicone oil removal in proliferative vitreoretinopathy: a prognostic factor analysis. Am J Ophthalmol (2008) 1.67
Prevalence and determinants of spectacle nonwear among rural Chinese secondary schoolchildren: the Xichang Pediatric Refractive Error Study Report 3. Arch Ophthalmol (2008) 1.67
Macular hole surgery with or without indocyanine green stained internal limiting membrane peeling. Clin Experiment Ophthalmol (2003) 1.64
An in vitro study of ceftazidime and vancomycin concentrations in various fluid media: implications for use in treating endophthalmitis. Invest Ophthalmol Vis Sci (2002) 1.62
Corneal hysteresis and axial length among Chinese secondary school children: the Xichang Pediatric Refractive Error Study (X-PRES) report no. 4. Am J Ophthalmol (2008) 1.59
Five-year follow up of selective laser trabeculoplasty in Chinese eyes. Clin Experiment Ophthalmol (2004) 1.58
Quality of reporting of key methodological items of randomized controlled trials in clinical ophthalmic journals. Ophthalmic Epidemiol (2007) 1.57
Pars plana vitrectomy in the management of retained intravitreal lens fragments after cataract surgery. Clin Experiment Ophthalmol (2002) 1.54
Ophthalmic manifestations and risk factors for mortality of HIV patients in the post-highly active anti-retroviral therapy era. Clin Experiment Ophthalmol (2010) 1.53
Laser peripheral iridoplasty as initial treatment of acute attack of primary angle-closure: a long-term follow-up study. J Glaucoma (2002) 1.53
Internal limiting membrane staining with various concentrations of indocyanine green dye under air in macular surgeries. Am J Ophthalmol (2003) 1.51
Assessment of macular function by multifocal electroretinography following epiretinal membrane surgery with indocyanine green-assisted internal limiting membrane peeling. Graefes Arch Clin Exp Ophthalmol (2006) 1.50
In vivo confocal microscopy of Thygeson's superficial punctate keratitis. Clin Experiment Ophthalmol (2004) 1.49
Visual sensation during phacoemulsification and intraocular lens implantation using topical and regional anesthesia. J Cataract Refract Surg (2004) 1.48
Anti-vascular endothelial growth factor treatment for eye diseases. BMJ (2012) 1.48
Silent cerebral infarct and visual field progression in newly diagnosed normal-tension glaucoma: a cohort study. Ophthalmology (2009) 1.48
Keratometry for intraocular lens power calculation using Orbscan II in eyes with laser in situ keratomileusis. J Refract Surg (2005) 1.47
Residual bed thickness and corneal forward shift after laser in situ keratomileusis. J Cataract Refract Surg (2004) 1.46
RETINAL VEIN OCCLUSIONS, FROM BASICS TO THE LATEST TREATMENT. Retina (2016) 1.45
Polyglactin sutures versus nylon sutures for suturing of conjunctival autograft in pterygium surgery: a randomized, controlled trial. Acta Ophthalmol Scand (2007) 1.45
Encapsulated triamcinolone cyst after subtenon injection. Clin Experiment Ophthalmol (2006) 1.44
Tyrosinase gene (TYR) mutations in Chinese patients with oculocutaneous albinism type 1. Clin Experiment Ophthalmol (2010) 1.43
Ptosis after laser in situ keratomileusis. J Cataract Refract Surg (2004) 1.43
Photodynamic therapy with or without intravitreal triamcinolone acetonide for symptomatic polypoidal choroidal vasculopathy. J Ocul Pharmacol Ther (2010) 1.43
A case series of contact lens-associated Fusarium keratitis in Hong Kong. Cornea (2007) 1.43
Association of complement factor H polymorphisms with exudative age-related macular degeneration. Mol Vis (2006) 1.41
Long-term success of argon laser peripheral iridoplasty in the management of plateau iris syndrome. Ophthalmology (2004) 1.40
Comparison of techniques for corneal power assessment after myopic LASIK without the use of preoperative data. J Refract Surg (2008) 1.40
Comparison of the Colvard pupillometer and the Zywave for measuring scotopic pupil diameter. J Refract Surg (2004) 1.40
Repeatability and reproducibility of pachymetric mapping with Visante anterior segment-optical coherence tomography. Invest Ophthalmol Vis Sci (2007) 1.39
Intraocular pressure measurement in patients with previous LASIK surgery using pressure phosphene tonometer. Clin Experiment Ophthalmol (2005) 1.39
Longitudinal variability of optic disc and retinal nerve fiber layer measurements. Invest Ophthalmol Vis Sci (2008) 1.38
Confirmation of bilateral corneal intraepithelial cystic lesions by confocal microscopy previously treated for meibomian gland dysfunction. Clin Experiment Ophthalmol (2003) 1.38
Different optineurin mutation pattern in primary open-angle glaucoma. Invest Ophthalmol Vis Sci (2003) 1.36
Intravitreal bevacizumab in inflammatory ocular neovascularization. Am J Ophthalmol (2008) 1.36
Visual disability, visual function, and myopia among rural chinese secondary school children: the Xichang Pediatric Refractive Error Study (X-PRES)--report 1. Invest Ophthalmol Vis Sci (2008) 1.34
Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: a prospective analysis of age-related loss. Ophthalmology (2012) 1.33
Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: analysis of the retinal nerve fiber layer map for glaucoma detection. Ophthalmology (2010) 1.30
Central corneal thickness measurements using Orbscan II, Visante, ultrasound, and Pentacam pachymetry after laser in situ keratomileusis for myopia. J Cataract Refract Surg (2007) 1.29
HTRA1 variants in exudative age-related macular degeneration and interactions with smoking and CFH. Invest Ophthalmol Vis Sci (2008) 1.28
Associations between near work, outdoor activity, and myopia among adolescent students in rural China: the Xichang Pediatric Refractive Error Study report no. 2. Arch Ophthalmol (2009) 1.28
Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: pattern of RNFL defects in glaucoma. Ophthalmology (2010) 1.27
Efficacy of 1.25 MG versus 2.5 MG intravitreal bevacizumab for diabetic macular edema: six-month results of a randomized controlled trial. Retina (2009) 1.27
Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes. Ophthalmology (2007) 1.26
Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study. Ophthalmology (2007) 1.26
Anterior chamber angle imaging with swept-source optical coherence tomography: an investigation on variability of angle measurement. Invest Ophthalmol Vis Sci (2011) 1.26
Presence of crystalline lens as a protective factor for the late development of open angle glaucoma after vitrectomy. Retina (2009) 1.25
TIGR/MYOC gene sequence alterations in individuals with and without primary open-angle glaucoma. Invest Ophthalmol Vis Sci (2002) 1.25
A genome-wide scan maps a novel juvenile-onset primary open-angle glaucoma locus to 15q. Invest Ophthalmol Vis Sci (2006) 1.23
A genome-wide scan maps a novel high myopia locus to 5p15. Invest Ophthalmol Vis Sci (2008) 1.21
Multiple gene polymorphisms in the complement factor h gene are associated with exudative age-related macular degeneration in chinese. Invest Ophthalmol Vis Sci (2008) 1.21
Graft-vs-host-disease-associated conjunctival chemosis and central serous chorioretinopathy after bone marrow transplant. Am J Ophthalmol (2002) 1.20
The clinical applications of multifocal electroretinography: a systematic review. Surv Ophthalmol (2007) 1.20
Genotype phenotype analysis of Bietti's crystalline dystrophy in patients with CYP4V2 mutations. Invest Ophthalmol Vis Sci (2007) 1.19